Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Prescribing behavior and marketing practices.

Stone AM.

Psychiatr Serv. 2006 Mar;57(3):419; author reply 419. No abstract available.

PMID:
16525009
2.

Patient- and facility-level factors associated with diffusion of a new antipsychotic in the VA health system.

Valenstein M, McCarthy JF, Ignacio RV, Dalack GW, Stavenger T, Blow FC.

Psychiatr Serv. 2006 Jan;57(1):70-6.

PMID:
16399965
3.

Variations in prescribing practices for novel antipsychotic medications among Veterans Affairs hospitals.

Owen RR, Feng W, Thrush CR, Hudson TJ, Austen MA.

Psychiatr Serv. 2001 Nov;52(11):1523-5.

PMID:
11684751
4.

Gender differences in antipsychotics prescribed to veterans with serious mental illness.

Schwartz E, Charlotte M, Slade E, Medoff D, Li L, Dixon L, Kilbourne A, Kreyenbuhl J.

Gen Hosp Psychiatry. 2015 Jul-Aug;37(4):347-51. doi: 10.1016/j.genhosppsych.2015.03.018. Epub 2015 Apr 1.

PMID:
25936673
5.

New schizophrenia drug.

[No authors listed]

FDA Consum. 2001 May-Jun;35(3):6. No abstract available.

6.

Use of electronic medical record data for quality improvement in schizophrenia treatment.

Owen RR, Thrush CR, Cannon D, Sloan KL, Curran G, Hudson T, Austen M, Ritchie M.

J Am Med Inform Assoc. 2004 Sep-Oct;11(5):351-7. Epub 2004 Jun 7.

7.

Combination antipsychotic therapy in clinical practice.

Parker GF.

Psychiatr Serv. 2003 Apr;54(4):574; author reply 574. No abstract available.

PMID:
12663851
8.

Industry-sponsored grand rounds and prescribing behavior.

Dieperink ME, Drogemuller L.

JAMA. 2001 Mar 21;285(11):1443-4. No abstract available.

PMID:
11255418
9.

Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.

Valenstein M, Copeland LA, Blow FC, McCarthy JF, Zeber JE, Gillon L, Bingham CR, Stavenger T.

Med Care. 2002 Aug;40(8):630-9.

PMID:
12187177
10.

Age-related modifiers of clinical presentation and health service use among veterans with bipolar disorder.

Sajatovic M, Blow FC, Ignacio RV, Kales HC.

Psychiatr Serv. 2004 Sep;55(9):1014-21. Erratum in: Psychiatr Serv. 2004 Dec;55(12):1442.

PMID:
15345761
11.

Ziprasidone augmentation of clozapine in 11 patients.

Kaye NS.

J Clin Psychiatry. 2003 Feb;64(2):215-6. No abstract available.

PMID:
12633133
12.

Ziprasidone hydrochloride.

[No authors listed]

Am J Health Syst Pharm. 2002 Jan 1;59(1):28-9. No abstract available.

PMID:
11813463
13.

[Therapy of schizophrenia with high compliance. Ziprasidon increases pharmaceutical options].

[No authors listed]

Nervenarzt. 1999 Nov;70(11 Suppl Ziprasidon):1-4. German. No abstract available.

PMID:
10603602
14.

Ziprasidone hydrochloride approved for treatment of schizophrenia, but with major warning.

[No authors listed]

Am J Health Syst Pharm. 2001 May 1;58(9):758. No abstract available.

PMID:
11351914
15.
16.

Use of system-wide outcomes monitoring data to compare the effectiveness of atypical neuroleptic medications.

Sernyak MJ, Leslie D, Rosenheck R.

Am J Psychiatry. 2003 Feb;160(2):310-5.

PMID:
12562578
17.

Evaluation of health services use following the initiation of risperidone long-acting therapy among schizophrenia patients in the veterans health administration.

Ren XS, Crivera C, Sikirica M, Dirani R, Qian S, Kazis LE.

J Clin Pharm Ther. 2011 Jun;36(3):383-9. doi: 10.1111/j.1365-2710.2010.01211.x. Epub 2010 Nov 10.

PMID:
21062329
18.

Ziprasidone (Geodon) for schizophrenia.

[No authors listed]

Med Lett Drugs Ther. 2001 Jun 11;43(1106):51-2. No abstract available.

PMID:
11402259
19.

Factors in choosing atypical antipsychotics: toward understanding the bases of physicians' prescribing decisions.

Hoblyn J, Noda A, Yesavage JA, Brooks JO 3rd, Sheikh J, Lee T, Tinklenberg JR, Schneider B, O'Hara R, Leslie DL, Rosenheck RA, Kraemer HC.

J Psychiatr Res. 2006 Mar;40(2):160-6. Epub 2005 Sep 8.

PMID:
16150458
20.

Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study.

Wessels AM, Bies RR, Pollock BG, Schneider LS, Lieberman JA, Stroup S, Li CH, Coley K, Kirshner MM, Marder SR.

J Clin Pharmacol. 2011 Nov;51(11):1587-91. doi: 10.1177/0091270010387604. Epub 2011 Jan 5. No abstract available.

PMID:
21209243

Supplemental Content

Support Center